BACKGROUND: The neonatal innate immune system differs to microbial infection both quantitatively and qualitatively when compared with adults. Here, we provide the first genome-wide ex-vivo expression profile of umbilical cord blood (UCB) neutrophils from full-term infants prior to and in response to whole-blood lipopolysaccharide (LPS) stimulation. Additionally, we provide cytokine expression prior to and following LPS stimulation. The genomic expression and cytokine profile are compared with LPS-stimulated whole blood from healthy adult subjects (HC). METHODS: Whole blood from UCB (n = 6) and HC (n = 6) was studied at baseline or was stimulated for 24 h with 100 ngs/mL of LPS. CD66b neutrophils were subsequently isolated with microfluidic techniques and genome-wide expression analyses were performed. Ingenuity Pathway Analysis (IPA) software was utilized to predict downstream functional effects. Additionally, cytokine concentrations in whole blood prior to and after 24 h of LPS incubation were determined. RESULTS: LPS stimulated whole blood from UCB demonstrated significant differences in both ex-vivo cytokine production and PMN gene expression. Mixed-effect modeling identified 1,153 genes whose expression changed significantly in UCB and HC after exposure to LPS (P < 0.001 with a minimum 1.5-fold change). IPA downstream predictions suggest that PMNs from UCB fail to effectively upregulate genes associated with activation, phagocytosis, and chemotaxis in response to LPS stimulation. Furthermore, whole blood from UCB showed increased interleukin (IL)-10 production to LPS, but failed to significantly increase several pro-inflammatory cytokines. CONCLUSIONS: LPS-stimulated whole blood from UCB exhibited a markedly suppressed inflammatory cytokine production and PMN innate immune genome response. These differences in gene expression and cytokine production may be an adaptive response to a prior fetal environment, but may also explain their increased susceptibility to infections. Characterization of these deficits is the first step toward developing prophylactic and therapeutic interventions.
BACKGROUND: The neonatal innate immune system differs to microbial infection both quantitatively and qualitatively when compared with adults. Here, we provide the first genome-wide ex-vivo expression profile of umbilical cord blood (UCB) neutrophils from full-term infants prior to and in response to whole-blood lipopolysaccharide (LPS) stimulation. Additionally, we provide cytokine expression prior to and following LPS stimulation. The genomic expression and cytokine profile are compared with LPS-stimulated whole blood from healthy adult subjects (HC). METHODS: Whole blood from UCB (n = 6) and HC (n = 6) was studied at baseline or was stimulated for 24 h with 100 ngs/mL of LPS. CD66b neutrophils were subsequently isolated with microfluidic techniques and genome-wide expression analyses were performed. Ingenuity Pathway Analysis (IPA) software was utilized to predict downstream functional effects. Additionally, cytokine concentrations in whole blood prior to and after 24 h of LPS incubation were determined. RESULTS:LPS stimulated whole blood from UCB demonstrated significant differences in both ex-vivo cytokine production and PMN gene expression. Mixed-effect modeling identified 1,153 genes whose expression changed significantly in UCB and HC after exposure to LPS (P < 0.001 with a minimum 1.5-fold change). IPA downstream predictions suggest that PMNs from UCB fail to effectively upregulate genes associated with activation, phagocytosis, and chemotaxis in response to LPS stimulation. Furthermore, whole blood from UCB showed increased interleukin (IL)-10 production to LPS, but failed to significantly increase several pro-inflammatory cytokines. CONCLUSIONS:LPS-stimulated whole blood from UCB exhibited a markedly suppressed inflammatory cytokine production and PMN innate immune genome response. These differences in gene expression and cytokine production may be an adaptive response to a prior fetal environment, but may also explain their increased susceptibility to infections. Characterization of these deficits is the first step toward developing prophylactic and therapeutic interventions.
Authors: Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2011-04-25 Impact factor: 7.124
Authors: Oi Ning Fong; Kathy Yuen Yee Chan; Kam Tong Leung; Hugh Simon Lam; Hon Ming Cheung; Tak Yeung Leung; Karen Li; Pak Cheung Ng Journal: J Leukoc Biol Date: 2013-08-28 Impact factor: 4.962
Authors: Lori F Gentile; Dina C Nacionales; M Cecilia Lopez; Erin Vanzant; Angela Cuenca; Alex G Cuenca; Ricardo Ungaro; Ben E Szpila; Shawn Larson; Anna Joseph; Frederick A Moore; Christiaan Leeuwenburgh; Henry V Baker; Lyle L Moldawer; Philip A Efron Journal: J Immunol Date: 2014-03-03 Impact factor: 5.422
Authors: Tobias R Kollmann; Juliet Crabtree; Annie Rein-Weston; Darren Blimkie; Francis Thommai; Xiu Yu Wang; Pascal M Lavoie; Jeff Furlong; Edgardo S Fortuno; Adeline M Hajjar; Natalie R Hawkins; Steven G Self; Christopher B Wilson Journal: J Immunol Date: 2009-11-16 Impact factor: 5.422
Authors: Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black Journal: Lancet Date: 2012-05-11 Impact factor: 79.321
Authors: Claire L Smith; Paul Dickinson; Thorsten Forster; Marie Craigon; Alan Ross; Mizanur R Khondoker; Rebecca France; Alasdair Ivens; David J Lynn; Judith Orme; Allan Jackson; Paul Lacaze; Katie L Flanagan; Benjamin J Stenson; Peter Ghazal Journal: Nat Commun Date: 2014-08-14 Impact factor: 14.919
Authors: Steven L Raymond; Russell B Hawkins; Tyler J Murphy; Jaimar C Rincon; Julie A Stortz; María Cecilia López; Ricardo Ungaro; Felix Ellett; Henry V Baker; James L Wynn; Lyle L Moldawer; Daniel Irimia; Shawn D Larson Journal: J Mol Med (Berl) Date: 2018-05-28 Impact factor: 4.599
Authors: Steven L Raymond; Brittany J Mathias; Tyler J Murphy; Jaimar C Rincon; María Cecilia López; Ricardo Ungaro; Felix Ellett; Julianne Jorgensen; James L Wynn; Henry V Baker; Lyle L Moldawer; Daniel Irimia; Shawn D Larson Journal: Transl Res Date: 2017-09-01 Impact factor: 7.012
Authors: John T Benjamin; Daniel J Moore; Clayton Bennett; Riet van der Meer; Ashley Royce; Ryan Loveland; James L Wynn Journal: J Immunol Date: 2018-10-10 Impact factor: 5.422
Authors: Robert Para; Roberto Romero; Derek Miller; Jose Galaz; Bogdan Done; Azam Peyvandipour; Meyer Gershater; Li Tao; Kenichiro Motomura; Douglas M Ruden; Jenna Isherwood; Eunjung Jung; Tomi Kanninen; Roger Pique-Regi; Adi L Tarca; Nardhy Gomez-Lopez Journal: Immunohorizons Date: 2021-09-14
Authors: Steven L Raymond; Julie A Stortz; Juan C Mira; Shawn D Larson; James L Wynn; Lyle L Moldawer Journal: Front Pediatr Date: 2017-02-07 Impact factor: 3.418
Authors: Widad Dantoft; Pablo Martínez-Vicente; James Jafali; Lara Pérez-Martínez; Kim Martin; Konstantinos Kotzamanis; Marie Craigon; Manfred Auer; Neil T Young; Paul Walsh; Arnaud Marchant; Ana Angulo; Thorsten Forster; Peter Ghazal Journal: Front Immunol Date: 2017-09-25 Impact factor: 7.561